Found 43 matching trials
COr Loco-regional Advanced Lung Cancer Treated With Chemo-radiotherapy (COLA) N/A Patients with loco-regional NSCLC planned for curative treatment with chemo...
Show More Location
Odense University Hospital
Learn More & Join Trial
Olaparib & Radiation Therapy for Patients Triple Negative Breast Cancer (TNBC) PHASE1 A Phase I of Olaparib with Radiation Therapy in Patients With Inflammatory,...
Show More Learn More & Join Trial
Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck Cancers PHASE3 Study to evaluate the efficacy of treatment by radiotherapy and pembrolizum...
Show More Location
Institut Sainte Catherine
Learn More & Join Trial
Concurrent Hyperthermia and Chemoradiotherapy in LAPC: Phase II Study PHASE2 This is a phase II randomized study of concurrent chemoradiotherapy and loc...
Show More Location
Kantonsspital Aarau
Learn More & Join Trial
Cetuximab/Paclitaxel/Cisplatin Concurrent Chemoradiotherapy Followed by Esophagectomy for Loco-regional Esophageal Cancer PHASE2 We hypothesize that the addition of cetuximab to twice weekly paclitaxel/ci...
Show More Location
National Taiwan University Hospital
Learn More & Join Trial
Standard Maintenance Therapy (SMT) vs Local Consolidative Radiation Therapy and SMT in OM-NSCLC PHASE3 Standard Maintenance Therapy versus Local Consolidative Radiation Therapy a...
Show More Location
Tata Memorial Hospital, Parel
Learn More & Join Trial
Locoregional Treatment and Palbociclib in de Novo, Treatment Naive, Stage IV ER+, HER2- Breast Cancer Patients NA Approximately 3.5% to 6% of newly diagnosed breast cancer patients are stag...
Show More Status
Active Not Recruiting
Location
Institut de Cancérologie de l'Ouest-Site Paul Papin
Learn More & Join Trial
Hypofractionated Loco-regional Adjuvant Radiation Therapy of Breast Cancer Combined With a Simultaneous Integrated Boost NA The purpose of the study is to investigate the difference in late radiation...
Show More Status
Active Not Recruiting
Location
Aarhus University Hospital
Learn More & Join Trial
Personalization of Breast Radiotherapy According to Loco-regional Recurrence Risk and Toxicity Probability NA Our objective is based on a personalized approach of adjuvant breast radiot...
Show More Location
Institut Du Cancer de Montpellier
Learn More & Join Trial
Phase II Study of Radiotherapy Followed by Durvalumab and Ceralasertib in Stage III NSCLC Patients With Thoracic Relapses +/- Oligometastases After PACIFIC Regimen PHASE2 Aim of this phase 2 study is to explore the safety and efficacy of thoracic...
Show More Location
ASST degli Spedali Civili di Brescia
Learn More & Join Trial